Biotechnology Company

Zonare Medical Systems


Funding Goal
Funding Raised So Far $30,000,000
Funding Commitments $0
Funding Remaining
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

ZONARE Medical Systems, Inc. develops, manufactures, and commercializes compact ultrasound systems that are used for diagnostic imaging in a range of clinical applications and settings. Its product platform, the ultrasound system, is based on its unique data acquisition and image formation technology, Zone Sonography. Zone Sonography technology enables customers to maintain an ultrasound system, and add new clinical applications and advanced image processing capabilities. ZONARE Medical sells its systems through direct sales force in the United States, and through a combination of distributors and direct sales personnel in approximately 40 international markets. The company, formerly known as NovaSonics, Inc., was founded in 1999 and is headquartered in Mountain View, California.

Read More
lock icon

Unlock Company Profile

Sign up now to unlock full company profiles and access financials, investor documents, and engage companies.

Business Summary

Company Age 23 years, 11 months
Employees 14
Sub-Industry Other Biotechnology
Prior Year Revenue
Current Year Revenue
Next Year Revenue


Timothy A. Marcotte
Chief Executive Officer
Timothy A. Marcotte

Timothy A. Marcotte is the President & CEO at Zonare Medical Systems.

Timothy A. Marcotte has served as our President & CEO since February 2012. He joined ZONARE in October 2007 and his prior roles included Chief Operating Officer and Chief Financial Officer.

From April 2004 to October 2007, Mr. Marcotte served as Chief Financial Officer and Vice President, Finance and Administration of VNUS Medical Technologies, Inc., a medical device company.

From October 2002 to April 2004, Mr. Marcotte was an independent financial consultant.

Mr. Marcotte holds an M.B.A. and a B.S. in Anthropology/Zoology from the University of Michigan.

Glen W. McLaughlin
Chief Technology Officer
Glen W. McLaughlin

Glen W. McLaughlin (Ph.D.) is the Vice President & Chief Technology Officer at Zonare Medical Systems.

Glen W. McLaughlin, Ph.D. has served as our VP of Engineering and CTO since August 1999.

Prior to joining us, Dr. McLaughlin held engineering positions at In-Cube, Inc., a medical research laboratory, from July 1994 to July 1999 .

Cardiac Pathways Corp., a medical device company, from 1992 to 1994.

Dr. McLaughlin holds a Ph.D. in Electrical Engineering from Stanford University.

B.S. in Electrical Engineering from Carnegie Mellon University.

M.S. from Stanford University.

Michael Gabler
Vice President Engineering
Michael Gabler

Michael Gabler is the Vice President, Engineering at Zonare Medical Systems.

Michael Gabler has been with ZONARE since March of 2004 and has risen through the ranks from Senior Engineer to his current position as VP of Engineering.

Prior to joining ZONARE, Michael spent 10 years with Aptix Corporation, an (EDA) Electronic Design Automation player as well as many years with EPRO, an innovator in low cost, high performance Integrated Circuit test systems.

Mr. Gabler is a 30 year veteran of Silicon Valley startups.

Mr. Gabler received his bachelor's degree from DeVry Institute of Technology in Phoenix, Arizona.

Priscilla J. Ryland
Vice President Business Development
Priscilla J. Ryland

Priscilla J. Ryland is the Vice President of Business Development & Corporate Accounts at Zonare Medical Systems.

Priscilla J. Ryland has served as our VP of Business Development & Corporate Accounts since October 2011.

From 2005 to 2011, Ms. Ryland served as National Accounts Manager where she managed and grew key relationships with,

Broadlane / MedAssets,

Department of Defense,

HealthTrust Purchasing Group,

Kaiser Permanente,

St. Jude Medical,

Sutter Health and other strategic partners.

Prior to joining ZONARE, she was with Siemens Medical Solutions USA, Inc. - Ultrasound Division and Acuson for 20 years, where she held various positions in Sales and National Accounts.

Ms. Ryland started her career in the clinical environment and graduated from the University of Texas Health Science Center in Houston.

Dan Bradford
Vice President
Dan Bradford

Dan Bradford is the Vice President of Operations at Zonare Medical Systems.

Dan Bradford joined ZONARE as VP of Operations in March 2012, bringing more than 25 years of operational experience within the medical device industry, including ultrasound. He has extensive expertise in the development and commercialization of complex, high-quality medical systems and bringing those products to the healthcare marketplace. He will oversee the customer support, quality, manufacturing, product service and regulatory teams.

Prior experiences to ZONARE included,

Vice President of Operations at Auxogyn, Inc,

Vice President of Operations at Hansen Medical, Inc.

as well as Sr. Director of Catheter Engineering.

Dan also was the Director of Program Management at Kyphon and Engineering Program Director at Siemens Medical Solutions Ultrasound Division where he held management positions in marketing, field operations and corporate quality at Acuson Corporation.

Tim Heher
Vice President
Tim Heher

Tim Heher is the Vice President, Finance at Zonare Medical Systems.

Tim Heher has served as our VP of Finance since December 2011.

Prior to joining us, Tim was CFO for Allocade Inc., where he was responsible for all finance and accounting activities, treasury, facilities, purchasing, order administration and human resources.

Prior to this Tim was the CFO at United Medical Instruments. Tim also held the positions of director of finance for sales, service and marketing and director of finance for supply chain management at Siemens Medical Solutions, Ultrasound Division.

Beginning in 1989, Tim joined Acuson Corporation and held several senior management positions in accounting and corporate finance. Acuson was acquired by Siemens Medical Solutions in November 2000.

Tim holds a Bachelor of Science in Finance and a Master of Business Administration in Finance and Marketing from Santa Clara University.

Thom Rasche
Thom Rasche

Thom E. Rasche is the Board Director at Zonare Medical Systems.

Thom E. Rasche has been a member of our board of directors since April 2004.

Since January 2007, Mr. Rasche has been a partner at Earlybird Venture Capital, a venture capital firm, where he previously served as a Venture Partner from July 2003 to December 2006.

Prior to joining Earlybird, Mr. Rasche was the Managing Director for ETHICON Endo-Surgery, a division of ETHICON GmbH (a Johnson & Johnson company), from January 2000 to June 2003.

Mr. Rasche holds a Degree as Diplom Kaufmann (M.B.A. equivalent) from the University of Applied Sciences in Lneburg, Germany, specializing in Marketing and Human Resource Management.

Joseph E. Whitters
Joseph E. Whitters

Joseph E. Whitters is the Board Director at Zonare Medical Systems.

He has served on ZONARE board of directors since January 2007.

Since October 2005, Mr. Whitters has been a Senior Advisor to Frazier Healthcare Ventures.

From October 1986 to January 2005, Mr. Whitters was with First Health Group Corp., or First Health, a managed healthcare company, where he held various financial positions and served as Chief Financial Officer from 1988 to 2004. First Health was sold to Coventry Health Care, Inc., a managed health care company, in 2005.

Mr. Whitters currently serves as the Chairman of the Board of
Mentor Corporation, a provider of products serving the aesthetic medicine market.

A Director of Omnicell, Inc., a provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities and Luminent Mortgage Capital Inc., a real estate investment trust.

Currently, Mr.

Rick Blume
Rick Blume

Rick Blume has been financing companies in healthcare for over three decades. His early investment banking career involved financing and banking relationships with hospitals, payers, physicians, and new biotech companies. The excitement he saw at Genentech, in its early years, led him to transition into venture capital in the mid 1980's. Rick co-founded CB Health Ventures in 1998 where he assembled what is now the core of Excel including Enrico Petrillo, M.D., Steve Gullans, PhD, and Tricia Moriarty.

Rick has served as a director or active investor in many companies including Lantos Technologies, Cytyc (acquired by Hologic - HOLX), AbT (now OSI - OSIP), Somatogen (acquired by Baxter - BAX), EdenTec (acquired by Nellcor), Exact Sciences (EXAS), IPC The Hospitalist Company (IPCM), GeneOhm (acquired by Becton Dickinson - BDX), Zonare, TransMedics, US Servis (acquired by McKesson); and the former public health insurance company Washington National.

Christopher Hollowood
Christopher Hollowood

Christopher Hollowood is the Board Director at Zonare Medical Systems.

Christopher Hollowood has served on ZONARE board of directors since June 2009.

Chris is a Partner of Syncona Partners LLP.

Previously, he was a Partner of Apposite Capital LLP, a leading venture and growth capital company focused on the healthcare and life science sector.

He was involved in a number of successful investments, which included Convergence Pharmaceuticals Ltd and the acquisition of a portfolio of 9 US healthcare companies.

Before Apposite, Chris had roles with Bioscience Managers Ltd, Neptune Investment Management Ltd and as a medicinal chemist in the pharmaceutical industry.

Chris holds a Degree in Natural Sciences and a PhD in Organic Chemistry, both from Cambridge University.

Nader J. Naini
Nader J. Naini

Nader J. Naini is the Board Director at Zonare Medical Systems.

Nader J. Naini has served on ZONARE board of directors since October 2001.

Mr. Naini joined Frazier Healthcare Ventures, a venture capital firm, shortly after its inception in 1991 and has been a General Partner and served on the firm's management committee since 1995.

Prior to joining Frazier Healthcare, Mr. Naini was with Goldman Sachs & Co.

Mr. Naini holds an M.B.A. from the Leonard N. Stern School of Business at New York University.

B.A. in molecular biology from the University of Pennsylvania.

Robert J. Gallagher

Robert J. Gallagher is the Board Director at Zonare Medical Systems.

Robert J. Gallagher has been a member of ZONARE board of directors since March 2002.

Mr. Gallagher has been retired since December 2000.

Mr. Gallagher served as interim President and Chief Operating Officer of Acuson, an ultrasound company, from February 2000 to December 2000.

From 1997 to 1999, Mr. Gallagher served as Acuson's Chief Operating Officer and Vice-Chairman of the board of directors, and as Acuson's President and Chief Operating Officer and a member of the board of directors from 1995 to 1997.

Mr. Gallagher joined Acuson in 1983 as Vice President of Finance and Chief Financial Officer.

Mr. Gallagher holds an M.B.A. from Stanford University.

B.S. Degree in Electrical Engineering from Rutgers University.


Funding Goal
Funding Raised So Far $30,000,000
Funding Commitments $0
Funding Remaining
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding



Zonare Medical Systems

Mountain View, CA 94035, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).